Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2225 of 2529 entries
View as:

Pharmacokinetics and Safety Study of Siremadlin (HDM201) in Participants With Mild, Moderate and Severe Hepatic Impairment

Phase: N/A Priority: Normal
NCT ID: NCT05599932 Org: User:
Start: 12/02/22 End: 09/18/23 Due: 09/18/24

Effects of Nateglinide vs Acarbose on Postprandial Glucose Fluctuation, Dyslipidemia, and Inflammatory Factors

Phase: N/A Priority: Normal
NCT ID: NCT00928889 Org: User:
Start: 07/31/09 End: 06/30/10 Due: 06/30/11

A Registry of Patients With Moderate to Severe Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT02786186 Org: User:
Start: 12/23/15 End: 12/31/25 Due: 12/31/26

Double-dose Valsartan Monotherapy in Hypertension Treatment: an Effectiveness and Safety Evaluation in Chinese Patients.

Phase: N/A Priority: Normal
NCT ID: NCT01541189 Org: User:
Start: 02/29/12 End: 01/31/13 Due: 01/31/14

Phase II Study Aiming to Evaluate the Efficacy and Safety of Nilotinib Patients With Gastrointestinal Stromal Tumors (GIST) Resistant or Intolerant to Imatinib and or to 2nd Line Tyrosine Kinas (TK) Inhibitor

Phase: N/A Priority: Normal
NCT ID: NCT00633295 Org: User:
Start: 06/30/08 End: 05/31/10 Due: 05/31/11

Ruxolitinib Managed Access Program (MAP) for Patients Diagnosed With Severe/Very Severe COVID-19 Illness

Phase: N/A Priority: Normal
NCT ID: NCT04337359 Org: User:
Start: - End: - Due: -

Bioavailability and Food Effect Study of TKI258 (CSF Capsules vs. FMI Capsules)in Adult Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01030055 Org: User:
Start: 02/28/10 End: 06/30/12 Due: 06/30/13

An Exploratory Haemodynamic Study in Patients With Compensated Cirrhosis and Portal Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01640964 Org: User:
Start: 04/30/13 End: 12/31/14 Due: 12/31/15

A Study of BKM120 in Adult Japanese Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01283503 Org: User:
Start: 10/31/09 End: 10/31/11 Due: 10/31/12

A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01440374 Org: User:
Start: 09/30/11 End: 12/31/15 Due: 12/31/16

A Study to Evaluate the Effect of Letrozole and Tamoxifen on Bone and Lipids in Postmenopausal Women With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00171704 Org: User:
Start: 04/30/05 End: 03/31/11 Due: 03/31/12

Efficacy and Safety of Fixed Combination Therapy of Vildagliptin and Metformin (25/1000 mg Bid) in Patients With Type 2 Diabetes Inadequately Controlled With Prior Metformin Monotherapy (HbA1c 7.0-9.5%)

Phase: N/A Priority: Normal
NCT ID: NCT00728351 Org: User:
Start: 06/30/08 End: - Due: -

Study Comparing Standard Dose and High-dose Imatinib Mesylate in Patients With Chronic Phase Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia (CML)

Phase: N/A Priority: Normal
NCT ID: NCT00171899 Org: User:
Start: 04/30/05 End: 06/30/07 Due: 06/30/08

A Phase I Study of BKM120 in Adult Chinese Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01626209 Org: User:
Start: 07/31/12 End: 04/30/14 Due: 04/30/15

Study Comparing Two VAY736 Drug Products in Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT03574545 Org: User:
Start: 12/19/18 End: 07/18/24 Due: 07/18/25

Safety and Efficacy of Galvus in Elderly Type 2 Diabetes Patients

Phase: N/A Priority: Normal
NCT ID: NCT01257451 Org: User:
Start: 12/31/10 End: 03/31/12 Due: 03/31/13

Efficacy, Safety and Tolerability of KAF156 in Combination With Lumefantrine Solid Dispersion Formulation (LUM-SDF) in Pediatric Population With Uncomplicated Plasmodium Falciparum Malaria

Phase: N/A Priority: Normal
NCT ID: NCT04546633 Org: User:
Start: 02/16/21 End: 08/28/24 Due: 08/28/25

A Study of MBG453 in Combination With Azacitidine and Venetoclax in AML Patients Unfit for Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT04150029 Org: User:
Start: 09/01/20 End: 10/25/24 Due: 10/25/25

Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration

Phase: N/A Priority: Normal
NCT ID: NCT01255462 Org: User:
Start: 11/30/10 End: 09/30/11 Due: 09/30/12

Safety and Efficacy of Deferasirox in Combination With Desferoxamine in β-thalassaemia Patients With Severe Cardiac Iron Overload

Phase: N/A Priority: Normal
NCT ID: NCT01459718 Org: User:
Start: 01/31/11 End: 06/30/14 Due: 06/30/15

Effect of Deferasirox on Endocrine Complications in Subjects With Transfusion Dependent Thalassemia

Phase: N/A Priority: Normal
NCT ID: NCT02069886 Org: User:
Start: 12/31/14 End: 12/31/18 Due: 12/31/19

Determine the Safety, Tolerability, and Efficacy of MAU868 for the Prevention of BK Virus Infection in Kidney Transplant Recipients

Phase: N/A Priority: Normal
NCT ID: NCT03456999 Org: User:
Start: 10/15/18 End: 11/16/20 Due: 11/16/21

Ofatumumab in Portuguese Multiple Sclerosis Patients - an Observational Study

Phase: N/A Priority: Normal
NCT ID: NCT05809986 Org: User:
Start: 11/27/23 End: 09/15/26 Due: 09/15/27

Study of Efficacy and Safety of Dabrafenib and Trametinib Combination Therapy in Japanese Patients With BRAF V600E Stage IV NSCLC

Phase: N/A Priority: Normal
NCT ID: NCT02672358 Org: User:
Start: 09/03/18 End: 12/07/20 Due: 12/07/21

Multiple-dose Regimen Study to Assess Effect of 12 Months of Secukinumab Treatment on Skin Response and Biomarkers in Psoriasis Patients

Phase: N/A Priority: Normal
NCT ID: NCT01537432 Org: User:
Start: 01/31/12 End: 12/31/14 Due: 12/31/15